Literature DB >> 25755386

Evaluation of liver transplant recipients.

Paul J Thuluvath1.   

Abstract

The outcome of liver transplantation (LT) is dependent on many factors including graft quality, surgical techniques, postoperative care, immunosuppressive regimens and most importantly, careful pre-transplant recipient evaluation and selection. Currently, the expected 1-year and 5-year survival rates after LT are 85-95% and 75-85%, respectively. The improvement in outcomes and better awareness has resulted in an increasing demand for LT around the world including India. Transplant physicians have responded to this increased demand by developing several strategies including the use of older donors, grafts from hepatitis C positive donors or those with previous hepatitis B infection (positive hepatitis B virus [HBV] core immunoglobulin G [IgG] antibody), graft from nonheart beating donors, domino transplantation (liver from patients with familial amyloid polyneuropathy transplanted into older recipients), split-liver grafts, and live donor liver transplant (LDLT). Currently, the only treatment that prolongs survival in those with end-stage acute or chronic liver failure is transplantation of either partial or full liver donor graft. Because of the enormous disparity in supply and demand for donor organs, costs, and potential morbidity and mortality of live donors in LDLT, it has become incumbent on the transplant community to ration the available organs in a way that provides the best outcomes and in the process, serves the best interest of the population as a whole. When evaluating a potential candidate for LT, it is imperative to determine whether the recipient is going to benefit from the procedure immediately and in the long-term. In this review, we will discuss the process of selection and optimal evaluation of potential LT recipients.

Entities:  

Keywords:  AFP, alfa-feto protein; ANA, anti-nuclear antibody; CMV, cytomegalovirus; CT, computed tomography; CTP, Child-Turcotte-Pugh; CXR, chest X-ray; DEXA, dual-emission X-ray absorptiometry; EBV, Epstein-Barr virus; EGD, esophagogastroduodenoscopy; ERCP, endoscopic retrograde cholangiopancreatography; FAP, familial amyloid polyneuropathy; HAV, hepatitis A virus; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSV, herpes simplex virus; HTN, hypertension; Hepatocellular carcinoma; INR, international normalized ratio; LDLT, live donor liver transplant; LT, liver transplantation; MELD, model for end-stage liver disease; MRI, magnetic resonance imaging; PSA, prostate-specific antigen; PSC, primary sclerosing cholangitis; RPR, rapid plasma reagin; live donor liver transplant; liver transplantation

Year:  2012        PMID: 25755386      PMCID: PMC3940623          DOI: 10.1016/S0973-6883(11)60238-7

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  15 in total

1.  American Society of Transplant Surgeons' position paper on adult-to-adult living donor liver transplantation.

Authors: 
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

2.  A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics.

Authors:  Paul J Thuluvath; Hwan Y Yoo; Richard E Thompson
Journal:  Liver Transpl       Date:  2003-05       Impact factor: 5.799

3.  An analysis of late deaths after liver transplantation.

Authors:  S Asfar; P Metrakos; J Fryer; D Verran; C Ghent; D Grant; M Bloch; P Burns; W Wall
Journal:  Transplantation       Date:  1996-05-15       Impact factor: 4.939

4.  Liver transplantation in the United States, 1999-2008.

Authors:  P J Thuluvath; M K Guidinger; J J Fung; L B Johnson; S C Rayhill; S J Pelletier
Journal:  Am J Transplant       Date:  2010-04       Impact factor: 8.086

5.  Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

6.  Outcome of liver transplantation in patients with diabetes mellitus: a case-control study.

Authors:  P R John; P J Thuluvath
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

7.  Ten years of liver transplantation: an evolving understanding of late graft loss.

Authors:  O Abbasoglu; M F Levy; B B Brkic; G Testa; D R Jeyarajah; R M Goldstein; B S Husberg; T A Gonwa; G B Klintmalm
Journal:  Transplantation       Date:  1997-12-27       Impact factor: 4.939

8.  Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus.

Authors:  Preeti R John; Paul J Thuluvath
Journal:  Liver Transpl       Date:  2002-08       Impact factor: 5.799

9.  Minimizing risk associated with elderly liver donors by matching to preferred recipients.

Authors:  Dorry L Segev; Warren R Maley; Christopher E Simpkins; Jayme E Locke; Geoffrey C Nguyen; Robert A Montgomery; Paul J Thuluvath
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation.

Authors:  Hwan Y Yoo; Paul J Thuluvath
Journal:  Transplantation       Date:  2002-10-15       Impact factor: 4.939

View more
  1 in total

1.  Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study.

Authors:  Emad Hamdy Gad; Ayman Alsebaey; Maha Lotfy; Mohamed Eltabbakh; Ahmed Alshawadfy Sherif
Journal:  Ann Med Surg (Lond)       Date:  2015-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.